Department of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, ON, Canada.
Blood. 2013 Mar 28;121(13):2432-9. doi: 10.1182/blood-2012-06-438481. Epub 2013 Jan 16.
Rapid boosting of memory CD8(+) T cells (TM) is essential in cancer immunotherapy and the control of certain infectious diseases. However, effector T cells (TE) are a barrier to booster vaccination because they can rapidly kill antigen-bearing antigen-presenting cells (APCs) before TM are engaged. We demonstrate that viral-vectored vaccines delivered by B cells elicit robust TM expansion in the presence of TE, enabling booster immunizations to bypass TE-mediated negative feedback regulation. Our data indicate that viral vector-loaded B cells home to the follicular regions in secondary lymphoid organs, which are anatomically separated from TE and in close proximity to TM. The B cells, however, do not serve as APCs in this area. Rather, classic CD11c(+) dendritic cells serve to stimulate the secondary CD8(+) T-cell response. Our data reveal that B cells represent a novel and readily accessible delivery system that can effectively engage secondary CD8(+) T-cell activation for prime-boost strategies.
快速增强记忆性 CD8(+)T 细胞(TM)对于癌症免疫疗法和某些传染病的控制至关重要。然而,效应 T 细胞(TE)是增强疫苗接种的障碍,因为它们可以在 TM 被激活之前迅速杀死携带抗原的抗原呈递细胞(APCs)。我们证明,B 细胞传递的病毒载体疫苗在 TE 存在的情况下会引发强烈的 TM 扩增,从而使增强免疫能够绕过 TE 介导的负反馈调节。我们的数据表明,负载病毒载体的 B 细胞归巢到次级淋巴器官的滤泡区,滤泡区在解剖学上与 TE 分离,并与 TM 接近。然而,B 细胞在该区域不作为 APC 起作用。相反,经典的 CD11c(+)树突状细胞可刺激次级 CD8(+)T 细胞反应。我们的数据表明,B 细胞代表了一种新型的、易于获得的传递系统,可有效引发次级 CD8(+)T 细胞的激活,从而用于初次-增强策略。